Abstract
The sodium-activated potassium channel Slack (KNa1.1, Slo2.2, or Kcnt1) is highly expressed in populations of sensory neurons, where it mediates the sodium-activated potassium current (IKNa) and modulates neuronal activity. Previous studies suggest that Slack is involved in the processing of neuropathic pain. However, mechanisms underlying the regulation of Slack activity in this context are poorly understood. Using whole-cell patch-clamp recordings we found that Slack-mediated IKNa in sensory neurons of mice is reduced after peripheral nerve injury, thereby contributing to neuropathic pain hypersensitivity. Interestingly, Slack is closely associated with ATP-sensitive P2X3 receptors in a population of sensory neurons. In vitro experiments revealed that Slack-mediated IKNa may be bidirectionally modulated in response to P2X3 activation. Moreover, mice lacking Slack show altered nocifensive responses to P2X3 stimulation. Our study identifies P2X3/Slack signaling as a mechanism contributing to hypersensitivity after peripheral nerve injury and proposes a potential novel strategy for treatment of neuropathic pain.
Keywords: Slack, P2X3, dorsal root ganglia, neuropathic pain, mice
1. Introduction
Neuropathic pain resulting from a lesion or disease of the nervous system affects 6.9–10% of the general population [1]. It is poorly managed by existing analgesic drugs, with less than half of patients achieving satisfactory pain relief [2]. Therefore, determining the molecular constituents of neuropathic pain processing remains an important endeavor of pain research [3,4,5].
The transmission and processing of pain rely critically on the activities of ion channels that are expressed in sensory neurons. Over the past few years, several ion channel subtypes have been implicated in pain signaling and are being pursued as novel targets for analgesic therapy [6]. Among the potential targets for treatment of neuropathic pain, the sodium (Na+)-dependent potassium (K+) channel Slack (also termed KNa1.1, Slo2.2, or Kcnt1) has gained recent interest. Slack is only weakly voltage-dependent and activated by intracellular Na+ [7,8,9,10], whereas its activity is inhibited by divalent cations that modify channel gating by an allosteric mechanism [11]. Slack is highly expressed in the isolectin B4 (IB4)-binding, non-peptidergic subpopulation of C fiber sensory neurons, and accumulating evidence implicates Slack in the processing of pain [12,13,14,15,16,17,18,19].
In a previous study, we generated Slack mutant mice and observed increased pain hypersensitivity of global and sensory neuron-specific Slack knockouts in models of neuropathic pain [15]. By contrast, their behavior in models of inflammatory and acute nociceptive pain was normal [15,18], suggesting a specific function of Slack in neuropathic pain processing. However, the mechanisms that regulate Slack activity in neuropathic pain remain elusive.
Here, we further characterized the functions of Slack in pain processing. We report that the potassium currents generated by Slack in non-peptidergic C fiber sensory neurons are diminished after peripheral nerve injury. Furthermore, we provide evidence that Slack is closely associated with ATP-sensitive P2X3 receptors, which are highly expressed in non-peptidergic C fiber sensory neurons and play an important role in peripheral sensitization during chronic pain (for review, see [20,21]. Our data suggest that a P2X3-mediated ion influx modulates the activity of Slack and thus regulates neuropathic pain sensitivity.
2. Results
2.1. Slack-/- Mice Show Increased Neuropathic Pain Behavior after Peripheral Nerve Injury
To evaluate the role of Slack in neuropathic pain processing, we exposed Slack-/- and wide-type (WT) mice to the spared nerve injury (SNI) model of experimental neuropathy, wherein the tibial and common peroneal nerves are ligated and transected while the sural nerve is left intact. Thirteen days after SNI, both genotypes developed mechanical hypersensitivity in the lateral hind paw region (innervated by the spared sural nerve), as indicated by decreases in mechanical thresholds in the von Frey test (Figure 1A). Notably, the extent of SNI-induced mechanical hypersensitivity was markedly increased in Slack-/- mice as compared to WT littermates (Figure 1A). These data confirm our findings in an earlier study, in which the mechanical hypersensitivity was measured using another method (Dynamic Plantar Aesthesiometer [15]). In addition, we assessed non-reflexive pain behavior using a dynamic weight-bearing device. As shown in Figure 1B, weight bearing on the ipsilateral hind paw was reduced after SNI in both genotypes. However, the weight-bearing reduction was more pronounced in Slack-/- mice as compared to WT littermates, indicating an increased neuropathic pain behavior in the absence of Slack. Furthermore, control experiments in dorsal root ganglia (DRGs) of naive WT and Slack-/- mice revealed similar mRNA expression levels of related potassium channels (Supplementary Figure S1A) and a similar percentage of DRG neuron populations positive for standard markers (Supplementary Figure S1B) in both genotypes, suggesting that there were no general impairments that might account for the observed behavioral phenotype in Slack-/- mice. Together, these data support an inhibitory role for Slack in the modulation of neuropathic pain.
2.2. Slack-Mediated Potassium Currents in Sensory Neurons are Reduced after Nerve Injury
In an earlier study we demonstrated that Slack is highly expressed in DRG neurons and that the vast majority (86.5%) of Slack-positive cells bind IB4, whereas 12.6% are positive for calcitonin gene-related peptide (CGRP), two markers of non-peptidergic and peptidergic C fiber sensory neurons, respectively [15]. Moreover, Slack has been shown to generate a sodium-activated outward potassium current (IKNa) in whole-cell voltage-clamp recordings on IB4-positive sensory neurons of naive mice [15,18,22]. To examine whether Slack-mediated IKNa is altered after peripheral nerve injury, we performed whole-cell patch-clamp recordings on IB4-positive sensory neurons of WT and Slack-/- mice 14–19 days after SNI. At a holding potential of −70 mV, a series of 500 ms-long test pulses ranging from −120 to +120 mV in intervals of 20 mV were applied in the presence of 140 mM extracellular NaCl. In sensory neurons of WT mice, the amplitude of the total outward K+ current (IK) was significantly reduced after the nerve injury compared to the non-injured control (Figure 2A,B). By contrast, the IK amplitude in sensory neurons of Slack-/- mice was at the level of WT mice post-SNI and not altered by SNI (Figure 2A,B). Moreover, under Na+-free conditions (i.e., after replacement of NaCl with choline chloride in the external solution) the IK amplitude was similar in all groups (Figure 2C,D). These data suggest that Slack-mediated IKNa in IB4-positive sensory neurons is reduced after peripheral nerve injury, thereby contributing to neuropathic pain hypersensitivity.
2.3. Unaltered Slack Expression in DRGs and the Spinal Cord after Spared Nerve Injury
We next asked whether a downregulation of Slack expression in sensory neurons might underlay the reduced IKNa after SNI in WT mice, because various potassium channels are downregulated at the transcriptional level during neuropathic pain [6]. However, immunostaining experiments using a specific anti-Slack antibody, whose immunoreactivity is absent in tissues from Slack-/- mice [15] and that does not cross-react with the closely related potassium channel Slick [18], showed that the percentage of Slack-immunoreactive sensory neurons was indistinguishable in DRGs of naive mice and 14 days after SNI (Figure 3A,B). Similarly, quantitative real-time reverse transcription PCR (qRT-PCR) analyses revealed unaltered Slack mRNA expression in lumbar DRGs 7 and 14 days after SNI (Figure 3C). Moreover, Slack immunoreactivity in the ipsilateral and contralateral dorsal horn of the lumbar spinal cord, in which the central terminals of sensory neurons terminate, was similar 14 days after SNI (Figure 3D). Accordingly, Western blot analyses of spinal cord tissue extracts did not detect any alteration of Slack expression in naive and post-SNI animals (Figure 3E,F). These data suggest that the expression of Slack channels, unlike many other potassium channels, is unaltered in sensory neurons in response to peripheral nerve injury.
2.4. Slack Channels Colocalize with P2X3 Receptors in Sensory Neurons
The unaltered Slack expression after SNI points to inhibition of Slack channel activity underlying the reduced IKNa after peripheral nerve injury. Because Slack channels are inhibited by intracellular Ca2+ and other divalent cations [11], we speculated that Ca2+-permeable ion channels in proximity to Slack channels might mediate the inhibition of IKNa in sensory neurons after nerve injury. Given the enriched expression of Slack in IB4-positive sensory neurons [15,23] and its functional contribution to neuropathic pain processing, we hypothesized several reasons why Slack might interact with the ATP receptor subunit P2X3: (i) P2X3 receptors, like Slack, are almost exclusively expressed in IB4-positive sensory neurons [24], (ii) they are permeable for Ca2+, Na+, and other cations, and (iii) signaling through P2X3 receptors essentially contributes to neuropathic pain hypersensitivity [25,26,27,28]. As shown in Figure 4A–C, the co-localization of Slack and P2X3 in DRG neurons is almost complete, as 97.1% of Slack-positive DRG neurons co-stained with P2X3 and 94.6% of P2X3-positive DRG neurons co-stained with Slack. Control experiments confirmed that almost all P2X3-positive DRG neurons bind IB4 (Figure S2C), suggesting that the anti-P2X3 antibody used in our immunostaining experiment is specific. Furthermore, Slack and P2X3 are also highly co-localized in the dorsal horn of the spinal cord (Figure 4D). Moreover, Western blot control experiments demonstrated similar P2X3 protein levels in DRGs and the spinal cord of Slack-/- and WT mice (Figure 4E,F) and P2X3 immunostaining detected a similar percentage of P2X3-positive DRG neurons in both genotypes (Figure 4G), suggesting that there was no compensatory regulation due to the Slack knockout that might have contributed to the observed pain behavior and neuronal potassium currents in Slack-/- mice. Together, these findings point to a possible interaction of Slack and P2X3 in sensory neurons.
2.5. P2X3 Activation Modulates Slack-Mediated Potassium Currents In Vitro
We next studied the functional properties of co-expressed recombinant Slack and P2X3 receptors. For that purpose, we used a commercially available HEK-293 cell line stably expressing human Slack channels (herein referred to as HEK-Slack cells) and transiently transfected GFP-tagged human P2X3 receptors into these cells. This strategy led to expression of P2X3 in about 40% of transfected cells (as indicated by green fluorescence in microscopy; the resulting P2X3-positive cells were referred to as HEK-Slack-P2X3 cells). We performed whole-cell patch-clamp recordings at a holding potential of −70 mV by applying series of 500 ms-long test pulses ranging from −120 to +120 mV in intervals of 20 mV. A first series of experiments were conducted using a physiological external solution (i.e., in the presence of 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, and 10 mM HEPES). As shown in Figure 5A–C, outward potassium currents (IK) were detected in both HEK-Slack and HEK-Slack-P2X3 cells. Interestingly however, the addition of the P2X3 agonist α,β-meATP (30 µM [29]) to the external solution reduced IK in HEK-Slack-P2X3 cells (Figure 5B,C) but not in HEK-Slack cells (Figure 5A). These results imply that P2X3 activation, which in our experimental setting may result in an influx of Na+, Mg2+, and Ca2+ [30,31], is associated with inhibition of Slack activity.
A recent study revealed that Slack activity is inhibited by divalent cations [11]. We reasoned that the observed reduction of IK in the presence of the P2X3 agonist might be mediated mainly by Ca2+, because Mg2+ represents a much weaker Slack inhibitor than Ca2+ [11]. To test this hypothesis, we performed experiments under Ca2+-free conditions, i.e., after replacement of Ca2+ in the external solution by Mg2+. Strikingly, in the absence of Ca2+ α,β-meATP increased IK in HEK-Slack-P2X3 cells but not in HEK-Slack cells (Figure 5D–F). We assumed that the increased IK was attributed to an exaggerated, Na+-mediated activation of Slack channels due to the lack of inhibition by Ca2+. Altogether, these data suggest that Slack-mediated IKNa may be bidirectionally modulated by a P2X3-driven ion influx.
2.6. P2X3-Mediated Ca2+ Influx Is Unaltered in Sensory Neurons of Slack-/- Mice
We next investigated the Slack-P2X3 interaction in sensory neurons. To exclude the possibility that a P2X3-driven Ca2+ influx in sensory neurons might be generally altered by Slack deficiency, we performed control experiments to analyze the α,β-meATP-evoked Ca2+ influx in sensory neurons of WT and Slack-/- mice. Calcium imaging in cultured lumbar DRG neurons of WT and Slack-/- mice revealed that incubation with α,β-meATP (30 µM [32]) evoked a similar calcium influx in both genotypes (Figure 6A). The magnitude of the Ca2+ response (Figure 6B,C) and the proportion of responsive DRG neurons (Figure 6D) were comparable in DRG neurons of WT and Slack-/- mice. These data confirm that Slack deficiency per se does not affect the P2X3-mediated Ca2+ influx in sensory neurons.
2.7. P2X3-Mediated Pain Behavior Is Altered in Slack-/- Mice
We then assessed a functional P2X3/Slack interaction in behavioral experiments in vivo. We injected α,β-meATP (12 nmol [26]) into a hind paw of naive WT and Slack-/- mice and analyzed the resulting paw-licking response over 10 min. Of note, during the first 2 min, the paw licking induced by α,β-meATP was significantly increased in Slack-/- mice as compared to WT mice (Figure 7A). Virtually no paw licking was observed at later time points (2–10 min) in both genotypes (Figure 7A), confirming earlier reports that the immediate nocifensive response to intraplantar α,β-meATP is relatively short-lived in naive animals [27]. After pretreatment with the selective P2X3 receptor antagonist AF353 (70 nmol intraplantar [33,34]) 10 min prior to the α,β-meATP injection, the paw-licking response was reduced, and no significant differences between groups were detected (Figure 7B). A similar paw-licking behavior occurred after injection of the vehicle (0.9% NaCl; Figure 7C), suggesting that the behavioral responses to the α,β-meATP injection shown in Figure 7A were mediated by P2X3 receptors. These data indicate that Slack channels control the immediate pronociceptive effects of P2X3 receptor activation in naive mice in vivo.
We next analyzed the P2X3/Slack interaction during neuropathic pain using the SNI model. For that purpose, α,β-meATP (12 nmol) was injected into the dorsolateral region of the ipsilateral hind paw 2–3 weeks after SNI. As shown in Figure 7D, in WT mice the paw-licking response after injection of α,β-meATP persisted over the 10 min observation period, which is in line with the sensitization of P2X3 receptors after traumatic injury that was reported in previous studies [26,27,35]. In Slack-/- mice, the paw-licking response was increased compared to WT mice in the first 2 min (with a similar licking time as observed in naive mice, see Figure 7A). During 2–6 min after the injection, the licking response was similar in Slack-/- and WT mice (and increased compared to naive mice, see Figure 7A), pointing to a sensitization of P2X3 receptors in both genotypes. Interestingly however, at late stages (6–10 min) the paw licking in Slack-/- mice was lower than in WT mice (Figure 7D). These data suggest that Slack facilitates the P2X3 receptor sensitization at late stages, which is in accordance with a Ca2+-driven inhibition of Slack channel activity in vivo.
3. Discussion
Here, we provide further support that Slack plays an important role in neuropathic pain processing. We uncovered Slack/P2X3 signaling as a new mechanism contributing to neuropathic pain processing. Strikingly, our data suggest that activation of P2X3 receptors may both activate and inhibit Slack, depending on P2X3 ion permeability. The main findings from this study are highlighted in a schematic diagram in Figure 8. Collectively, these data add to the complexity of ion channel regulation in sensory neurons during persistent pain.
Slack channels are widely distributed in the central and peripheral nervous systems. Previous studies detected particularly high Slack expression levels in IB4-positive, non-peptidergic sensory neurons [14,15,23,36], and behavioral analyses of global and sensory neuron-specific Slack knockout mice uncovered an inhibitory function of Slack in the processing of neuropathic pain [15]. These observations are further supported by a recent clinical trial using the Slack activator loxapine [19], pointing to Slack as a potential novel target to alleviate chronic pain in humans. We here confirm that Slack modulates neuropathic pain processing, because Slack-/- mice demonstrated an increased mechanical hypersensitivity (assessed using von Frey filaments) and a decreased weight distribution on the ipsilateral hind paw (assessed using dynamic weight bearing) after peripheral nerve injury.
Our data further expand the role of Slack in neuropathic pain by demonstrating that IKNa in IB4-positive sensory neurons, which is mainly driven by Slack, is reduced after peripheral nerve injury. In general, under neuropathic pain conditions there is a reduction in the expression of several subtypes of potassium channels that gives rise to hyperexcitability [6,37]. Prominent examples of downregulated potassium channels in DRG neurons after peripheral nerve injury include Kv9.1 [3,38], Kv1.1, and Kv1.2 [39,40]. Our observation that, unlike these channels, Slack expression in DRGs and the spinal cord is not altered after peripheral nerve injury further supports the idea that Slack might be a target for pain therapy.
Our study uncovered P2X3 as a previously unrecognized signaling pathway that regulates Slack activity. Previously identified Na+-permeable ion channels that may activate Slack include AMPA receptors [41] and Nav1.8 channels [22]. It has been shown that Na+ entering a neuron via a small but persistent sodium current may be effective in activating IKNa, even in the absence of bulk internal Na+ [10]. Furthermore, a recent study demonstrated that Slack is inhibited by divalent cations, most likely by an allosteric mode of action involving a His residue downstream S6 that is analogous to an inhibitory cation binding site in cyclic nucleotide gated channels [11]. We here demonstrate that a P2X3-driven ion influx may both stimulate and inhibit Slack activity: (i) In HEK-Slack-P2X3 cells, the addition of the P2X3 agonist α,β-meATP to the extracellular solution reduced IK in presence of Ca2+, whereas it increased IK under Ca2+-free conditions. (ii) In naive mice, paw injection of α,β-meATP induced paw licking in a Slack-dependent manner that was blocked by pretreatment with the P2X3 antagonist AF353. The reduced paw licking of WT mice as compared to Slack-/- mice suggests that a P2X3-driven Na+ influx activates Slack, which in turn limits the nocifensive behavior. (iii) After SNI, the paw licking evoked by α,β-meATP was ameliorated in Slack-/- mice at late stages (6–10 min). The longer lasting paw licking in WT mice indicates that a P2X3-driven Ca2+ influx might inhibit Slack, thereby facilitating the nocifensive behavior. However, it should be taken into account that α,β-meATP is an agonist not only at P2X3 but also at other P2X receptors [42,43] and that AF353 also inhibits P2X2/3 heteromeric receptors [34]. Hence, P2X receptors different from P2X3 might theoretically contribute to the observed pain behavior after α,β-meATP administration.
It is important to note that, in addition to ion influx, Slack activity may be modulated by protein kinase A [13,17], NAD+ [12], a Na+ sensor in the RCK2 domain [44], and TMEM16C [14]. On the other hand, different firing modalities have been detected after incubation of trigeminal neurons with α,β-meATP, suggesting that the co-expression of P2X3 with different interacting proteins might affect the firing responses [45]. In general, several factors have been identified that may interact with P2X receptors. In particular, P2X receptors may physically interact with members of the Cys-loop receptor family such as nicotinic, GABAA/C, and 5-HT3A receptors [46,47,48,49,50]. A recent study revealed that P2X3 receptors in sensory neurons tightly associate with acid-sensing ion channels, thereby forming a protein complex that mediates unidirectional inhibition [51]. Furthermore, protein modifications such as glycosylation can affect the function of ion channels at the level of subunit assembly, protein trafficking, ligand binding, and channel opening. It has been shown that glycosylation also affects proper folding, oligomeric association, and compartmentalization of P2X3 receptors in neuronal cells [52,53]. Hence, the P2X3–Slack interaction we report here further contributes to the complexity of pain processing.
In conclusion, our study suggests that Slack controls the excitability of IB4-positive sensory neurons under neuropathic pain conditions and that their activity is regulated by P2X3 receptors. Thus, targeting these channels might prove to be a new direction for the treatment of neuropathic pain.
4. Materials and Methods
4.1. Animals
Generation of global Slack mutants (Slack-/-) by a targeted ablation of Slack gene Kcnt1 in murine embryonic stem cells in combination with a common Cre/loxP system has been described previously [15]. Experiments were performed in mice of either sex backcrossed onto a C57BL/6N background. Littermate mice were used in all behavioral and patch-clamp studies, and were investigated by an observer blinded for the genotype and treatment of the animals. In addition, C57BL/6N mice from Charles River laboratories (Sulzfeld, Germany) were used for qRT-PCR and immunoblotting analyses. Animals were housed on a 12/12 light/dark cycle with access to food and water ad libitum. All experiments adhered to the International Association for the Study of Pain (IASP) and the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines, the 3Rs principles, and were approved by our local Ethics Committees for Animal Research (Regierungspräsidium Darmstadt, Germany (protocol V54-19c20/15-F95/45 with approval date 3 May 2012 and protocol V54-19c20/15-FR/1013 with approval date 17 May 2018) and Landesamt für Natur, Umwelt und Verbraucherschutz NRW, Recklinghausen, Germany (protocol 84-02.04.2015.A119 with approval date 1 October 2015)).
4.2. Behavioral Testing
4.2.1. Spared Nerve Injury Model of Neuropathic Pain
The SNI model of neuropathic pain was performed as described previously [54,55]. Under isoflurane anesthesia and carprofen analgesia, the common peroneal and tibial nerve branches of the sciatic nerve were ligated with a 6–0 silk suture and approximately 1 mm of the two nerve branches was removed distally, whereas the sural nerve was left intact.
For testing mechanical sensitivity, mice were placed in boxes on an elevated metal mesh floor and habituated for at least 30 min before behavioral testing began. Calibrated von Frey filaments ranging from 0.40 to 39.2 mN (0.02 to 4.0 g; Ugo Basile, Gemonio, Italy) were applied to the lateral part of the hind paw (sural nerve area) until they bowed for 5 s. Only obvious withdrawal responses to the applied stimulus were recorded. The 50% withdrawal thresholds were assessed using the up-down method [56,57] and calculated using an online algorithm (https://bioapps.shinyapps.io/von_frey_app/ [58]).
An automated dynamic weight-bearing (DWB) device (Bioseb, Vitrolles, France) was used to evaluate the dynamic weight distribution in mice after SNI. The system automatically records the average weight (in grams) that each limb exerts on a floor equipped with pressure transducers. A zone was considered valid when the following parameters were detected: ≥ 0.8 g on 1 captor with a minimum of 2 adjacent captors recording ≥ 1.0 g. For testing, the mouse was placed in the chamber and allowed to move freely within the apparatus for 10 min and videotaped. After 5 min of acclimatization, the dynamic weight distribution was recorded for 5 min. In all video sequences, the positions of the paws were manually validated by the observer [59,60]. The results were expressed as percent weight borne by the ipsilateral hind paw of total weight borne by both hind paws [61].
4.2.2. α,β-meATP-Induced Paw Licking
The animals were placed into a plexiglass cylinder (diameter 30 cm) and habituated for at least 30 min. α,β-Methylene adenosine 5′-triphosphate (α,β-meATP; 12 nmol in 12 µL 0.9% saline [26]; Sigma-Aldrich, Darmstadt, Germany), AF353 (70 nmol in 12 µL 0.9% saline [33]; Sigma-Aldrich), or 0.9% saline (B. Braun, Melsungen, Germany) was injected into the dorsolateral hind paw and the time spent licking the injected paw was scored for 10 min. In experiments with two compounds, AF353 was injected 10 min prior to α,β-meATP.
4.3. Quantitative Real-Time Reverse Transcription PCR
Mice were killed by CO2 inhalation and their lumbar (L4-L5) DRGs were rapidly dissected, snap frozen in liquid nitrogen, and stored at −80 °C. Total RNA was extracted under RNase-free conditions using an RNA isolation Kit (RNAqueous Micro Kit; Ambion/Life Technologies, Carlsbad, USA) according to the manufacturer’s instructions, and DNase treated for 15 min to minimize genomic DNA contamination and quantified with a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, USA). cDNA was synthesized from 200 ng RNA, random hexamer primers, RT-Enhancer, and the Verso enzyme of the Verso Kit (Thermo Fisher Scientific, Frankfurt, Germany). Quantitative real-time reverse transcription PCR (qRT-PCR) was performed on a 7500 Fast Real-Time PCR System (Applied Biosystems/Life Technologies) using Taqman gene expression assays for Kcnt1 (catalog no. Mm01330653_m1), Kcnma1 (catalog no. Mm01119505_m1), Kcnt2 (catalog no. Mm01284549_m1), and GAPDH (catalog no. Mm99999915_g1), all purchased from Applied Biosystems. Reactions (total volume 10 µl) were performed in duplicate or triplicate by incubating at 95 °C for 10 min, followed by 40 cycles of 15 s at 95 °C and 1 min at 60 °C. Water controls were included to ensure specificity. Relative expression of target gene levels was determined using the comparative 2-ΔΔCt method, with Ct indicating the cycle number at which the signal of the PCR product crossed an arbitrary threshold set within the exponential phase of the PCR. The amount of sample RNA was normalized to GAPDH.
4.4. Immunostaining
Mice were killed by CO2 and immediately perfused intracardially with 0.9% saline, followed by 1% paraformaldehyde in phosphate-buffered saline (PBS), pH 7.4. The lumbar (L4-L5) DRGs and spinal cord were dissected and cryoprotected in 20% sucrose overnight. Tissues were frozen in tissue-freezing medium (Leica, Nussloch, Germany) on dry ice, cryostat sectioned at a thickness of 14 µm, and stored at −80 °C. For immunostaining, sections were permeabilized for 5 min in 0.1% Triton X-100 in PBS, blocked for 1 h using 10% normal goat serum and 3% bovine serum albumin (BSA) in PBS, and incubated with primary antibodies diluted in 3% BSA in PBS overnight at 4 °C or for 2 h at room temperature. The following antibodies were used: mouse anti-slo2.2 (1:400, 75-051, NeuroMab; Davis, USA) [15], rabbit anti-P2X3 (1:800, AB5895, Sigma-Aldrich, Darmstadt, Germany) [18,62], rabbit anti-CGRP (1:800, PC205L, Calbiochem/Sigma-Aldrich) [15,63], mouse anti-NF200 (1:2000, N0142, Sigma-Aldrich) [64,65] and rabbit anti-tyrosin hydroxylase (1:400, AB152, Millipore/Sigma-Aldrich). Sections were then washed in PBS and stained with secondary antibodies conjugated with Alexa Fluor 488 (AF488) or Alexa Fluor 555 (1:1200, Thermo Fisher Scientific). For staining with tubulin β 3 (TUBB3), sections were incubated with AF488-conjuagted TUBB3 (1:1000, 801203, Biolegend, San Diego, USA) in PBS. For IB4 binding, sections were incubated with AF488-conjuagated IB4 (1:400, 121411, Invitrogen/Thermo Fisher Scientific) in PBS containing 1 mM CaCl2·2H2O, 1 mM MgCl2, 1 mM MnCl2, and 0.2% Triton X-100, pH 7.4). After immunostaining, slides were immersed for 5 min in 0.06% Sudan black B (in 70% ethanol) to reduce lipofuscin-like autofluorescence [66], washed in PBS, and coverslipped. In double-labeling experiments, primary antibodies were consecutively incubated. Images were taken using an Eclipse Ni-U (Nikon, Düsseldorf, Germany) microscope equipped with a monochrome CCD camera, and were pseudocolored and superimposed. Adjustment of brightness and contrast was done using Adobe Photoshop 2020 software (Adobe Systems). Controls were performed by omitting the first or the second antibodies, or both, and by incubating tissues of Slack-/- mice.
For cell counting, serial DRG sections from 3 mice per genotype were processed and at least 3 sections per DRG per animal were counted. Only cells showing staining clearly above the background were included. Specificity of Slack immunoreactivity was confirmed by simultaneous staining of co-embedded tissues of WT and Slack-/- mice. The percentage of Slack-positive or P2X3-positive cells was calculated as a proportion of positive cells per total number of DRG neurons.
4.5. Western Blot
The lumbar (L4-L5) DRGs and spinal cord were rapidly dissected, frozen in liquid nitrogen, and stored at −80 °C until use. For Slack detection, samples were homogenized in buffer containing 100 mM Tris-HCl and 1 mM MgCl2, pH 8.0, combined with a protease inhibitor mixture (Pierce Protease Inhibitor Mini Tablets; Thermo Scientific). After freezing for 30 min at −80 °C, samples were homogenized again. Then a sixfold volume of sucrose buffer (250 mM sucrose, 10 mM Tris-HCl, pH 7.4, combined with protease inhibitor mixture) was added followed by centrifugation at 1000 x g for 20 min. The supernatant was collected and centrifuged at 20,000 x g for 20 min, and the resulting pellets were resuspended in sucrose buffer [15]. For P2X3 detection, samples were homogenized in radioimmunoprecipitation assay (RIPA) buffer containing 150 mM NaCl, 50 mM Tris, 0.5% sodium deoxycholate, 0.1% SDS, and 1% Triton X-100, pH 8.0, combined with protease inhibitor mixture, and centrifuged at 12,000 x g for 30 min. Extracted proteins (30 µg/lane) were separated by SDS-PAGE and blotted onto a nitrocellulose membrane. After blocking nonspecific binding sites with blocking buffer (PBS with 3% low-fat milk) for 1 h, membranes were incubated with mouse anti-slo2.2 (1:500), rabbit anti-P2X3 (1:500), mouse anti-α-tubulin (1:800, Millipore/Sigma-Aldrich), or mouse anti-GAPDH (1:2000; Thermo Fisher Scientific) dissolved in blocking buffer containing 0.1% Tween 20 overnight at 4 °C. After incubation with secondary antibodies (IRDye® 680LT goat anti-mouse IgG1, IRDye® 680RD goat anti-rabbit IgG, IRDye® 800RD goat anti-rabbit IgG, or IRDye® 800RD goat anti-mouse IgG from LI-COR Bioscience, Bad Homburg, Germany) for 1 h at room temperature, proteins were detected using an Odyssey Infrared Imaging System or a C-DiGit blot scanner (LI-COR Bioscience).
4.6. Patch Clamp Recordings
A DRG neuron primary cell culture was prepared as described before [15]. Briefly, mice were killed by CO2 inhalation, and lumbar (L4-L5) DRGs were transferred to dulbecco’s modified eagle´s medium containing 50 μg/mL gentamicin (Sigma Aldrich). Following treatment with 500 U/mL collagenase IV and 2.5 U/mL dispase II for 30 min (both from Sigma Aldrich) and 0.05% Trypsin/ethylenediaminetetraacetic acid (Gibco/Thermo Fisher Scientific) for 10 min, cells were mechanically dissociated using a pipette. Isolated cells were transferred onto poly-D-lysine-coated (200 μg/mL, Sigma Aldrich) coverslips and cultured in TNB 100 medium supplemented with TNB 100 lipid protein complex, 100 μg/mL streptomycin, and penicillin (all from Biochrom, Berlin, Germany) at 37 °C and 5% CO2. To avoid neurite outgrowth, which could cause variations in expressed types and amounts of current, and to circumvent space clamp problems, the DRG neurons were studied within 24 h after plating [15,67].
HEK293 cells stably transfected with human Kcnt1 (referred to as HEK-Slack cells; SB-HEK-KCa4.1; SB Drug Discovery, Lanarkshire, UK) were cultured in minimum essential medium with 10% fetal calf serum, supplemented with 2 mM L-glutamine and 0.6 mg/mL G-418 (all from Gibco/Thermo Fisher Scientific) at 37 °C and 5% CO2. To obtain HEK-Slack cells that additionally express P2X3 (referred to as HEK-Slack-P2X3 cells), transient transfections of human P2X3 (NM_002559) were done with a pIRES2-EGFP vector plasmid (kindly provided by Prof. Dr. Peter Illes, University of Leipzig, Germany) and Roti-Fect transfection reagent (Carl Roth, Karlsruhe, Germany) according to the manufacturer’s instructions. Cells were split every 3 to 4 days and seeded 2 days before experiments.
Whole-cell voltage clamp recordings were conducted with an EPC 9 amplifier combined with Patchmaster software (HEKA Electronics, Lambrecht/Pfalz, Germany). Currents were filtered at 5 kHz and sampled at 20 kHz. Offline analyses were performed using the Fitmaster software (HEKA Electronics). IK were elicited by protocols consisting of 500 ms-long test pulses ranging from −120 to +120 mV in steps of 20 mV. The holding potential was −70 mV. The pipette solution contained 140 mM KCl, 2 mM MgCl2, 5 mM EGTA, and 10 mM HEPES and was adjusted to pH 7.4 with KOH. The physiological external solution contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, and 10 mM HEPES and was adjusted to pH 7.4 with NaOH. In a Na+-free external solution, NaCl was replaced with 140 mM choline chloride. In a Ca2+-free external solution, CaCl2 was replaced with 2 mM MgCl2 to obtain a final concentration of 4 mM MgCl2. Patch pipettes were fabricated with borosilicate glass (Science Products, Hofheim am Taunus, Germany) using a conventional puller (Flaming/Brown Micropipette Puller, Sutter Instruments, Novato, USA) and heat-polished to give a pipette resistance of 3–5 MΩ. Shortly before a coverslip was mounted for recordings, it was dipped in extracellular solution containing 10 μg/mL fluorescein isothiocyanateconjugated IB4 (Sigma-Aldrich) for 5–10 min, and only IB4-binding DRG neurons were analyzed. All recordings were made at 37 °C. α,β-meATP (Sigma-Aldrich) was added with a pipette to the bath chamber to reach a final concentration of 30 µM [29], and IK was recorded 5 min after α,β-meATP administration.
4.7. Calcium Imaging
Calcium imaging experiments were performed 24 h after DRG preparation [63]. Neurons were loaded with 5 µM Fura-2-AM-ester (Biotium, Fremont, USA) in supplemented Neurobasal Medium for 45 min at 37 °C, transferred to the perfusion chamber, and continuously superfused with a physiological Ringer solution (145 mM NaCl, 1.25 mM CaCl2, 1 mM MgCl2, 5 mM KCl, 10 mM Glucose, and 10 mM HEPES, pH 7.4, adjusted with NaOH). For calcium imaging, a Nikon Eclipse Ts2R inverse microscope equipped with a complete illumination system (DG4, Sutter Instruments), a Hamamatsu digital camera (ORCA-05G), Fura-2 filters, and a motorized microscope stage (Märzhäuser Wetzlar, Wetzlar, Germany) was used. Images were taken every 2 s at two wavelengths (340 and 380 nm) and were processed using the NIS-Elements software (Nikon). Baseline measurements were performed in Ringer solution at a flow rate of 1–2 mL/min. For stimulation, 30 μM α,β-meATP dissolved in Ringer solution was applied by bath perfusion for 30 s at room temperature. At the end of each measurement, cells were stimulated for 20 s with 75 mM KCl to identify viable neurons for evaluation. A calcium response was defined as a simultaneous increase at 340 nm and a decrease at 380 nm, when the 340/380 nm ratio normalized to baseline exceeded 20% of the baseline level. Acquired images were displayed as the 340/380 nm ratio.
4.8. Experimental Design and Statistical Analyses
Data are expressed as mean ± SEM. All statistical analysis was performed with GraphPad Prism version 8 for windows. p values < 0.05 were considered statistically significant. Single comparisons were performed using Student’s t-test. For behavioral experiments, two-way ANOVA (time x genotype) was used to measure effects across time between groups. Multiple comparisons between groups were performed using Sidak’s correction. Numbers of experiments (cells or mice) and statistical results are provided in the results section and the figure legends.
Acknowledgments
We thank Sylvia Oßwald, Cyntia Schäfer, Uli Hermanni, and Clement Kabagema-Bilan for excellent technical assistance and Peter Illes, Leipzig University, Germany, for providing the P2X3 vector plasmid.
Abbreviations
α,β-meATP | α,β-Methylene adenosine 5′-triphosphate |
AF488 | Alexa Fluor 488 |
CGRP | Calcitonin gene-related peptide |
DRG | Dorsal root ganglion |
GFP | Green fluorescent protein |
IB4 | Griffonia simplicifolia isolectin B4 |
IK | K+ current |
IKNa | Na+-activated outward K+ current |
I-V | Current-Voltage |
NF200 | Neurofilament 200 |
PBS | Phosphate-buffered saline |
qRT-PCR | Quantitative real-time reverse transcription PCR |
RIPA | Radioimmunoprecipitation assay |
Slack | Sequence like a Ca2+-activated K+ channel |
SNI | Spared nerve injury |
TUBB3 | Tubulin β 3 |
WT | Wild-type |
Supplementary Materials
The following are available online at https://www.mdpi.com/1422-0067/22/1/405/s1.
Author Contributions
Conceptualization, R.L. (Ruirui Lu), P.R., R.L. (Robert Lukowski), and A.S.; Methodology, R.L. (Ruirui Lu), K.M., R.E. and A.B. (Anne Bausch); Investigation, R.L. (Ruirui Lu), K.M., F.Z., C.F., A.B. (Annika Balzulat), P.E. and J.P.; writing—original draft preparation, R.L. (Ruirui Lu) and K.M.; writing—review and editing, R.L. (Ruirui Lu) and A.S.; supervision, R.L. (Ruirui Lu) and A.S.; project administration, R.L. (Ruirui Lu); funding acquisition, R.L. (Ruirui Lu) and A.S. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by the Else Kröner-Fresenius-Stiftung (2018_A95 to A.S.) and the Deutsche Forschungsgemeinschaft (LU 2514/1-1 to R.L. (Ruirui Lu)).
Institutional Review Board Statement
All animal experiments in this study were approved by our local Ethics Committees for Animal Research (Regierungspräsidium Darmstadt, Germany [protocol V54-19c20/15-F95/45 with approval date 3 May 2012 and protocol V54-19c20/15-FR/1013 with approval date 17 May 2018] and Landesamt für Natur, Umwelt und Verbraucherschutz NRW, Recklinghausen, Germany [protocol 84-02.04.2015.A119 with approval date 1 October 2015]).
Informed Consent Statement
Not applicable.
Data Availability Statement
Data is contained within the article or supplementary material.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.van Hecke O., Austin S.K., Khan R.A., Smith B.H., Torrance N. Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain. 2014;155:654–662. doi: 10.1016/j.pain.2013.11.013. [DOI] [PubMed] [Google Scholar]
- 2.Finnerup N.B., Attal N., Haroutounian S., McNicol E., Baron R., Dworkin R.H., Gilron I., Haanpää M., Hansson P., Jensen T.S., et al. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol. 2015;14:162–173. doi: 10.1016/S1474-4422(14)70251-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tsantoulas C., Denk F., Signore M., Nassar M.A., Futai K., McMahon S.B. Mice lacking Kcns1 in peripheral neurons show increased basal and neuropathic pain sensitivity. Pain. 2018;159:1641–1651. doi: 10.1097/j.pain.0000000000001255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cohen S.P., Mao J. Neuropathic pain: Mechanisms and their clinical implications. BMJ. 2014;348 doi: 10.1136/bmj.f7656. [DOI] [PubMed] [Google Scholar]
- 5.Chen L., Mao J. Update on neuropathic pain treatment: Ion channel blockers and gabapentinoids. Curr. Pain Headache Rep. 2013;17 doi: 10.1007/s11916-013-0359-2. [DOI] [PubMed] [Google Scholar]
- 6.Waxman S.G., Zamponi G.W. Regulating excitability of peripheral afferents: Emerging ion channel targets. Nat. Neurosci. 2014;17:153–163. doi: 10.1038/nn.3602. [DOI] [PubMed] [Google Scholar]
- 7.Hite R.K., MacKinnon R. Structural Titration of Slo2.2, a Na+-Dependent K+ Channel. Cell. 2017;168:390–399.e11. doi: 10.1016/j.cell.2016.12.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bader C.R., Bernheim L., Bertrand D. Sodium-activated potassium current in cultured avian neurones. Nature. 1985;317:540–542. doi: 10.1038/317540a0. [DOI] [PubMed] [Google Scholar]
- 9.Yuan A., Santi C.M., Wei A., Wang Z.W., Pollak K., Nonet M., Kaczmarek L., Crowder C.M., Salkoff L. The sodium-activated potassium channel is encoded by a member of the Slo gene family. Neuron. 2003;37:765–773. doi: 10.1016/S0896-6273(03)00096-5. [DOI] [PubMed] [Google Scholar]
- 10.Budelli G., Hage T.A., Wei A., Rojas P., Jong Y.J., O’Malley K., Salkoff L. Na+-activated K+ channels express a large delayed outward current in neurons during normal physiology. Nat. Neurosci. 2009;12:745–750. doi: 10.1038/nn.2313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Budelli G., Sun Q., Ferreira J., Butler A., Santi C.M., Salkoff L. SLO2 Channels Are Inhibited by All Divalent Cations That Activate SLO1 K+ Channels. J. Biol. Chem. 2016;291:7347–7356. doi: 10.1074/jbc.M115.709436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tamsett T.J., Picchione K.E., Bhattacharjee A. NAD+ activates KNa channels in dorsal root ganglion neurons. J. Neurosci. 2009;29:5127–5134. doi: 10.1523/JNEUROSCI.0859-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nuwer M.O., Picchione K.E., Bhattacharjee A. PKA-induced internalization of slack KNa channels produces dorsal root ganglion neuron hyperexcitability. J. Neurosci. 2010;30:14165–14172. doi: 10.1523/JNEUROSCI.3150-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Huang F., Wang X., Ostertag E.M., Nuwal T., Huang B., Jan Y.N., Basbaum A.I., Jan L.Y. TMEM16C facilitates Na+-activated K+ currents in rat sensory neurons and regulates pain processing. Nat. Neurosci. 2013;16:1284–1290. doi: 10.1038/nn.3468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lu R., Bausch A.E., Kallenborn-Gerhardt W., Stoetzer C., Debruin N., Ruth P., Geisslinger G., Leffler A., Lukowski R., Schmidtko A. Slack channels expressed in sensory neurons control neuropathic pain in mice. J. Neurosci. 2015;35:1125–1135. doi: 10.1523/JNEUROSCI.2423-14.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Evely K.M., Pryce K.D., Bausch A.E., Lukowski R., Ruth P., Haj-Dahmane S., Bhattacharjee A. Slack KNa Channels Influence Dorsal Horn Synapses and Nociceptive Behavior. Mol. Pain. 2017;13 doi: 10.1177/1744806917714342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gururaj S., Evely K.M., Pryce K.D., Li J., Qu J., Bhattacharjee A. Protein kinase A-induced internalization of Slack channels from the neuronal membrane occurs by adaptor protein-2/clathrin-mediated endocytosis. J. Biol. Chem. 2017;292:19304–19314. doi: 10.1074/jbc.M117.804716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Martinez-Espinosa P.L., Wu J., Yang C., Gonzalez-Perez V., Zhou H., Liang H., Xia X.M., Lingle C.J. Knockout of Slo2.2 enhances itch, abolishes KNa current, and increases action potential firing frequency in DRG neurons. eLife. 2015;4 doi: 10.7554/eLife.10013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Schmiedl S., Peters D., Schmalz O., Mielke A., Rossmanith T., Diop S., Piefke M., Thurmann P., Schmidtko A. Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability. Front. Pharmacol. 2019;10:838. doi: 10.3389/fphar.2019.00838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Burnstock G. Purinergic Mechanisms and Pain. Adv. Pharmacol. 2016;75:91–137. doi: 10.1016/bs.apha.2015.09.001. [DOI] [PubMed] [Google Scholar]
- 21.Krajewski J.L. P2X3-Containing Receptors as Targets for the Treatment of Chronic Pain. Neurotherapeutics. 2020;17:826–838. doi: 10.1007/s13311-020-00934-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Pryce K.D., Powell R., Agwa D., Evely K.M., Sheehan G.D., Nip A., Tomasello D.L., Gururaj S., Bhattacharjee A. Magi-1 scaffolds NaV1.8 and Slack KNa channels in dorsal root ganglion neurons regulating excitability and pain. FASEB J. 2019;33:7315–7330. doi: 10.1096/fj.201802454RR. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Usoskin D., Furlan A., Islam S., Abdo H., Lonnerberg P., Lou D., Hjerling-Leffler J., Haeggstrom J., Kharchenko O., Kharchenko P.V., et al. Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing. Nat. Neurosci. 2015;18:145–153. doi: 10.1038/nn.3881. [DOI] [PubMed] [Google Scholar]
- 24.Vulchanova L., Riedl M.S., Shuster S.J., Stone L.S., Hargreaves K.M., Buell G., Surprenant A., North R.A., Elde R. P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur. J. Neurosci. 1998;10:3470–3478. doi: 10.1046/j.1460-9568.1998.00355.x. [DOI] [PubMed] [Google Scholar]
- 25.Fabbretti E. ATP P2X3 receptors and neuronal sensitization. Front. Cell Neurosci. 2013;7:236. doi: 10.3389/fncel.2013.00236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chen Y., Li G.W., Wang C., Gu Y., Huang L.Y. Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state. Pain. 2005;119:38–48. doi: 10.1016/j.pain.2005.09.007. [DOI] [PubMed] [Google Scholar]
- 27.Xiang Z., Xiong Y., Yan N., Li X., Mao Y., Ni X., He C., LaMotte R.H., Burnstock G., Sun J. Functional up-regulation of P2X3 receptors in the chronically compressed dorsal root ganglion. Pain. 2008;140:23–34. doi: 10.1016/j.pain.2008.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Richards D., Gever J.R., Ford A.P., Fountain S.J. Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation. Br. J. Pharmacol. 2019;176:2279–2291. doi: 10.1111/bph.14677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hausmann R., Bodnar M., Woltersdorf R., Wang H., Fuchs M., Messemer N., Qin Y., Gunther J., Riedel T., Grohmann M., et al. ATP binding site mutagenesis reveals different subunit stoichiometry of functional P2X2/3 and P2X2/6 receptors. J. Biol. Chem. 2012;287:13930–13943. doi: 10.1074/jbc.M112.345207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Virginio C., North R.A., Surprenant A. Calcium permeability and block at homomeric and heteromeric P2X2 and P2X3 receptors, and P2X receptors in rat nodose neurones. J. Physiol. 1998;510:27–35. doi: 10.1111/j.1469-7793.1998.027bz.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Simonetti M., Fabbro A., D’Arco M., Zweyer M., Nistri A., Giniatullin R., Fabbretti E. Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin. Mol. Pain. 2006;2 doi: 10.1186/1744-8069-2-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Grundy L., Daly D.M., Chapple C., Grundy D., Chess-Williams R. TRPV1 enhances the afferent response to P2X receptor activation in the mouse urinary bladder. Sci. Rep. 2018;8 doi: 10.1038/s41598-017-18136-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kaan T.K., Yip P.K., Patel S., Davies M., Marchand F., Cockayne D.A., Nunn P.A., Dickenson A.H., Ford A.P., Zhong Y., et al. Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain. 2010;133:2549–2564. doi: 10.1093/brain/awq194. [DOI] [PubMed] [Google Scholar]
- 34.Gever J.R., Soto R., Henningsen R.A., Martin R.S., Hackos D.H., Panicker S., Rubas W., Oglesby I.B., Dillon M.P., Milla M.E., et al. AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. Br. J. Pharmacol. 2010;160:1387–1398. doi: 10.1111/j.1476-5381.2010.00796.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Fabbretti E. P2X3 receptors are transducers of sensory signals. Brain Res. Bull. 2019;151:119–124. doi: 10.1016/j.brainresbull.2018.12.020. [DOI] [PubMed] [Google Scholar]
- 36.Zeisel A., Hochgerner H., Lonnerberg P., Johnsson A., Memic F., van der Zwan J., Haring M., Braun E., Borm L.E., La Manno G., et al. Molecular Architecture of the Mouse Nervous System. Cell. 2018;174:999–1014.e22. doi: 10.1016/j.cell.2018.06.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tsantoulas C., McMahon S.B. Opening paths to novel analgesics: The role of potassium channels in chronic pain. Trends Neurosci. 2014;37:146–158. doi: 10.1016/j.tins.2013.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Tsantoulas C., Zhu L., Shaifta Y., Grist J., Ward J.P., Raouf R., Michael G.J., McMahon S.B. Sensory neuron downregulation of the Kv9.1 potassium channel subunit mediates neuropathic pain following nerve injury. J. Neurosci. 2012;32:17502–17513. doi: 10.1523/JNEUROSCI.3561-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Liang L., Gu X., Zhao J.Y., Wu S., Miao X., Xiao J., Mo K., Zhang J., Lutz B.M., Bekker A., et al. G9a participates in nerve injury-induced Kcna2 downregulation in primary sensory neurons. Sci. Rep. 2016;6 doi: 10.1038/srep37704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Calvo M., Richards N., Schmid A.B., Barroso A., Zhu L., Ivulic D., Zhu N., Anwandter P., Bhat M.A., Court F.A., et al. Altered potassium channel distribution and composition in myelinated axons suppresses hyperexcitability following injury. eLife. 2016;5 doi: 10.7554/eLife.12661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Nanou E., Kyriakatos A., Bhattacharjee A., Kaczmarek L.K., Paratcha G., El Manira A. Na+-mediated coupling between AMPA receptors and KNa channels shapes synaptic transmission. Proc. Natl. Acad. Sci. USA. 2008;105:20941–20946. doi: 10.1073/pnas.0806403106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Wildman S.S., Brown S.G., Rahman M., Noel C.A., Churchill L., Burnstock G., Unwin R.J., King B.F. Sensitization by extracellular Ca2+ of rat P2X5 receptor and its pharmacological properties compared with rat P2X1. Mol. Pharmacol. 2002;62:957–966. doi: 10.1124/mol.62.4.957. [DOI] [PubMed] [Google Scholar]
- 43.Mo G., Bernier L.P., Zhao Q., Chabot-Dore A.J., Ase A.R., Logothetis D., Cao C.Q., Seguela P. Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors. Mol. Pain. 2009;5 doi: 10.1186/1744-8069-5-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zhang Z., Rosenhouse-Dantsker A., Tang Q.Y., Noskov S., Logothetis D.E. The RCK2 domain uses a coordination site present in Kir channels to confer sodium sensitivity to Slo2.2 channels. J. Neurosci. 2010;30:7554–7562. doi: 10.1523/JNEUROSCI.0525-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hullugundi S.K., Ferrari M.D., van den Maagdenberg A.M., Nistri A. The mechanism of functional up-regulation of P2X3 receptors of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine type 1 (FHM-1) PLoS ONE. 2013;8:e60677. doi: 10.1371/journal.pone.0060677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Khakh B.S., Zhou X., Sydes J., Galligan J.J., Lester H.A. State-dependent cross-inhibition between transmitter-gated cation channels. Nature. 2000;406:405–410. doi: 10.1038/35019066. [DOI] [PubMed] [Google Scholar]
- 47.Barajas-Lopez C., Montano L.M., Espinosa-Luna R. Inhibitory interactions between 5-HT3 and P2X channels in submucosal neurons. Am. J. Physiol. Gastrointest. Liver Physiol. 2002;283:G1238–G1248. doi: 10.1152/ajpgi.00054.2002. [DOI] [PubMed] [Google Scholar]
- 48.Boue-Grabot E., Emerit M.B., Toulme E., Seguela P., Garret M. Cross-talk and co-trafficking between rho1/GABA receptors and ATP-gated channels. J. Biol. Chem. 2004;279:6967–6975. doi: 10.1074/jbc.M307772200. [DOI] [PubMed] [Google Scholar]
- 49.Xia R., Mei Z.Z., Milligan C., Jiang L.H. Inhibitory interaction between P2X4 and GABAC ρ1 receptors. Biochem. Biophys. Res. Commun. 2008;375:38–43. doi: 10.1016/j.bbrc.2008.07.096. [DOI] [PubMed] [Google Scholar]
- 50.Khakh B.S., Fisher J.A., Nashmi R., Bowser D.N., Lester H.A. An angstrom scale interaction between plasma membrane ATP-gated P2X2 and α4β2 nicotinic channels measured with fluorescence resonance energy transfer and total internal reflection fluorescence microscopy. J. Neurosci. 2005;25:6911–6920. doi: 10.1523/JNEUROSCI.0561-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Stephan G., Huang L., Tang Y., Vilotti S., Fabbretti E., Yu Y., Norenberg W., Franke H., Goloncser F., Sperlagh B., et al. Author Correction: The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel. Nat. Commun. 2018;9:3351. doi: 10.1038/s41467-018-05621-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Vacca F., Amadio S., Sancesario G., Bernardi G., Volonte C. P2X3 receptor localizes into lipid rafts in neuronal cells. J. Neurosci. Res. 2004;76:653–661. doi: 10.1002/jnr.20069. [DOI] [PubMed] [Google Scholar]
- 53.Vacca F., D’Ambrosi N., Nestola V., Amadio S., Giustizieri M., Cucchiaroni M.L., Tozzi A., Velluz M.C., Mercuri N.B., Volonte C. N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP. Glycobiology. 2011;21:634–643. doi: 10.1093/glycob/cwq211. [DOI] [PubMed] [Google Scholar]
- 54.Decosterd I., Woolf C.J. Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain. 2000;87:149–158. doi: 10.1016/S0304-3959(00)00276-1. [DOI] [PubMed] [Google Scholar]
- 55.Bourquin A.F., Suveges M., Pertin M., Gilliard N., Sardy S., Davison A.C., Spahn D.R., Decosterd I. Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain. 2006;122:14.e1–14.e14. doi: 10.1016/j.pain.2005.10.036. [DOI] [PubMed] [Google Scholar]
- 56.Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 1994;53:55–63. doi: 10.1016/0165-0270(94)90144-9. [DOI] [PubMed] [Google Scholar]
- 57.Dixon W.J. Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 1980;20:441–462. doi: 10.1146/annurev.pa.20.040180.002301. [DOI] [PubMed] [Google Scholar]
- 58.Christensen S.L., Hansen R.B., Storm M.A., Olesen J., Hansen T.F., Ossipov M., Izarzugaza J.M.G., Porreca F., Kristensen D.M. Von Frey testing revisited: Provision of an online algorithm for improved accuracy of 50% thresholds. Eur. J. Pain. 2020;24:783–790. doi: 10.1002/ejp.1528. [DOI] [PubMed] [Google Scholar]
- 59.Pitzer C., Kuner R., Tappe-Theodor A. EXPRESS: Voluntary and evoked behavioral correlates in neuropathic pain states under different housing conditions. Mol. Pain. 2016;12 doi: 10.1177/1744806916656635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Stark A., Schwenk R., Wack G., Zuchtriegel G., Hatemler M.G., Brautigam J., Schmidtko A., Reichel C.A., Bischoff I., Furst R. Narciclasine exerts anti-inflammatory actions by blocking leukocyte-endothelial cell interactions and down-regulation of the endothelial TNF receptor 1. FASEB J. 2019;33:8771–8781. doi: 10.1096/fj.201802440R. [DOI] [PubMed] [Google Scholar]
- 61.Majuta L.A., Longo G., Fealk M.N., McCaffrey G., Mantyh P.W. Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor. Pain. 2015;156:157–165. doi: 10.1016/j.pain.0000000000000017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Han L., Ma C., Liu Q., Weng H.J., Cui Y., Tang Z., Kim Y., Nie H., Qu L., Patel K.N., et al. A subpopulation of nociceptors specifically linked to itch. Nat. Neurosci. 2013;16:174–182. doi: 10.1038/nn.3289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Lu R., Lukowski R., Sausbier M., Zhang D.D., Sisignano M., Schuh C.D., Kuner R., Ruth P., Geisslinger G., Schmidtko A. BKCa channels expressed in sensory neurons modulate inflammatory pain in mice. Pain. 2014;155:556–565. doi: 10.1016/j.pain.2013.12.005. [DOI] [PubMed] [Google Scholar]
- 64.Petersen J., Mergia E., Kennel L., Drees O., Steubing R.D., Real C.I., Kallenborn-Gerhardt W., Lu R., Friebe A., Koesling D., et al. Distinct functions of soluble guanylyl cyclase isoforms NO-GC1 and NO-GC2 in inflammatory and neuropathic pain processing. Pain. 2018;160:607–618. doi: 10.1097/j.pain.0000000000001440. [DOI] [PubMed] [Google Scholar]
- 65.Kallenborn-Gerhardt W., Hohmann S.W., Syhr K.M., Schroder K., Sisignano M., Weigert A., Lorenz J.E., Lu R., Brune B., Brandes R.P., et al. Nox2-dependent signaling between macrophages and sensory neurons contributes to neuropathic pain hypersensitivity. Pain. 2014;155:2161–2170. doi: 10.1016/j.pain.2014.08.013. [DOI] [PubMed] [Google Scholar]
- 66.Schmidtko A., Gao W., Sausbier M., Rauhmeier I., Sausbier U., Niederberger E., Scholich K., Huber A., Neuhuber W., Allescher H.D., et al. Cysteine-rich protein 2, a novel downstream effector of cGMP/cGMP-dependent protein kinase I-mediated persistent inflammatory pain. J. Neurosci. 2008;28:1320–1330. doi: 10.1523/JNEUROSCI.5037-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Everill B., Kocsis J.D. Nerve growth factor maintains potassium conductance after nerve injury in adult cutaneous afferent dorsal root ganglion neurons. Neuroscience. 2000;100:417–422. doi: 10.1016/S0306-4522(00)00263-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data is contained within the article or supplementary material.